Evoq unveils smartphone-based retinal health test

By NS Medical Staff Writer

23 Nov 21

SmartERG Platform is capable of collecting and analysing data on the smartphone of the user, under the guidance…

DevicesOphthalmic

LumiThera to buy modern visual electrophysiology solutions provider Diopsys

By NS Medical Staff Writer

12 Nov 21

The acquisition will enable LumiThera to add a complementary diagnosis and monitoring platform to its treatment platform using…

DevicesOphthalmic

Alcon to buy eye disease technologies developer Ivantis for $475m

By NS Medical Staff Writer

09 Nov 21

The acquisition will enable Alcon to expand its portfolio across cataract, refractive, retina and glaucoma, in addition to…

DevicesOphthalmic

Ocular Therapeutix’s dry eye disease insert fails in phase 2 trial

By NS Medical Staff Writer

25 Oct 21

Conducted at 15 sites in the US, the randomised, double-masked, multi-centre and vehicle-controlled clinical trial was conducted to…

DevicesOphthalmic

FDA approves Luminopia’s digital therapeutic to enhance vision in children with lazy eye

By NS Medical Staff Writer

21 Oct 21

The new digital therapeutic enables patients to watch therapeutically modified TV shows and movies to enhance their vision…

DevicesOphthalmic

BVI invests in Elbit’s medical technology subsidiary Beyeonics Vision

By NS Medical Staff Writer

04 Oct 21

Beyeonics One is claimed to be the first and only commercial ophthalmic digital imaging system that can replace…

DevicesOphthalmic

Glaukos, Ivantis settle patent dispute over Hydrus Microstent

By NS Medical Staff Writer

16 Sep 21

Glaukos and Ivantis will submit a joint request to terminate the pending legal dispute, and dismiss it upon…

DevicesOphthalmic

Johnson & Johnson Vision Receives Approval in Canada for ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management

By NS Medical Staff Writer

09 Sep 21

First daily wear lens from Johnson & Johnson Vision, specifically designed for slowing the progression of myopia in…

DevicesOphthalmic

Glaukos seeks FDA approval for iStent infinite trabecular micro-bypass system

By NS Medical Staff Writer

06 Sep 21

The iStent infinite is an investigational device intended for use in a standalone procedure to minimise elevated intraocular…

DevicesOphthalmic

Visus, DelSiTech to develop new ophthalmic drug delivery technology

By NS Medical Staff Writer

20 Aug 21

DelSiTech will support Visus Therapeutics to develop investigational treatments for intraocular administration using a biodegradable, silica-based and sustained-release…

DevicesOphthalmic